Quick Comparison

ALCARL-Theanine
Half-Life4-5 hours2.5-4.5 hours
Typical DosageStandard: 500-2000 mg daily in 1-2 doses. For cognitive support: 1000-2000 mg daily. For neuropathy: 1500-3000 mg daily. Take in the morning — may be mildly stimulating.Standard: 100-200 mg daily. With caffeine: 100-200 mg L-Theanine per 50-100 mg caffeine (2:1 or 1:1 ratio). Can be taken up to 400 mg daily safely.
AdministrationOral (capsules, powder). Well-absorbed on an empty stomach.Oral (capsules, powder, naturally in green tea). 100% bioavailable orally.
Research Papers9 papers10 papers
Categories

Mechanism of Action

ALCAR

ALCAR crosses the blood-brain barrier via the organic cation transporter (OCTN2) more effectively than L-carnitine. In neurons, it is hydrolyzed by carnitine acetyltransferase to donate its acetyl group to coenzyme A, forming acetyl-CoA—which can then be used for acetylcholine synthesis via choline acetyltransferase, effectively providing raw material for the memory neurotransmitter. ALCAR also transports long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase system for beta-oxidation and ATP production. ALCAR activates nerve growth factor (NGF) signaling, possibly through modulation of NGF receptor (TrkA) expression or downstream MAPK/ERK pathways. It has antioxidant properties, reducing lipid peroxidation in mitochondrial membranes and scavenging free radicals. These mechanisms support cognitive function and neuroprotection.

L-Theanine

L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1/SLC7A5) and exerts anxiolytic effects through multiple pathways. It increases GABA synthesis by serving as a substrate for glutamate decarboxylase (GAD), elevating inhibitory tone without directly binding GABA-A receptors — avoiding sedation. It modulates serotonin by increasing tryptophan hydroxylase (TPH2) activity and raises dopamine levels in the prefrontal cortex via inhibition of dopamine reuptake. L-Theanine antagonizes glutamate binding at AMPA and kainate receptor subtypes (GluA1-4, GluK1-5), reducing excitatory neurotransmission and excitotoxicity risk. This glutamate antagonism, combined with increased GABA, drives the characteristic increase in alpha brain wave power (8-14 Hz) in the posterior parietal and occipital cortex — the EEG signature of relaxed alertness. When co-administered with caffeine, L-theanine attenuates caffeine-induced increases in blood pressure and anxiety by modulating sympathetic nervous system activation through alpha-2 adrenergic receptor pathways, while caffeine's dopaminergic and adenosine-blocking effects on focus and attention are preserved.

Risks & Safety

ALCAR

Common

Nausea, fishy body odor, restlessness, gastrointestinal discomfort.

Serious

May increase agitation in Alzheimer's patients. TMAO production may be a cardiovascular concern with chronic high doses.

Rare

Seizures in susceptible individuals, increased thyroid activity.

L-Theanine

Common

Very few side effects at standard doses. Mild drowsiness in some individuals.

Serious

None documented. Extremely safe with decades of human consumption data.

Rare

Headache, dizziness, gastrointestinal discomfort.

Full Profiles